“Growing Demand for Drug Delivery Applications”
The mesoporous silica market is experiencing significant growth due to its increasing use in drug delivery systems. Mesoporous silica nanoparticles (MSNs) provide controlled release and targeted delivery of pharmaceuticals, enhancing therapeutic efficacy and minimizing side effects. For instance, they are widely used in delivering anti-cancer drugs such as doxorubicin, offering precision in treatment. In addition, MSNs' tunable pore sizes and biocompatibility make them ideal carriers for various drugs, including peptides and nucleic acids. The pharmaceutical industry's rising focus on nanotechnology and precision medicine has amplified investments in mesoporous silica research, fostering market growth. This trend underscores its critical role in advancing innovative healthcare solutions.
